Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes
Abstract Prediction models for population-based screening need, for global usage, to be resource-driven, involving predictors that are affordably resourced. Here, we report the development and validation of three resource-driven risk models to identify people with type 2 diabetes (T2DM) at risk of s...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ed6372bb348e41e0939b2808d1e378b6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ed6372bb348e41e0939b2808d1e378b6 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ed6372bb348e41e0939b2808d1e378b62021-12-02T18:18:58ZDevelopment and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes10.1038/s41598-021-93096-w2045-2322https://doaj.org/article/ed6372bb348e41e0939b2808d1e378b62021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-93096-whttps://doaj.org/toc/2045-2322Abstract Prediction models for population-based screening need, for global usage, to be resource-driven, involving predictors that are affordably resourced. Here, we report the development and validation of three resource-driven risk models to identify people with type 2 diabetes (T2DM) at risk of stage 3 CKD defined by a decline in estimated glomerular filtration rate (eGFR) to below 60 mL/min/1.73m2. The observational study cohort used for model development consisted of data from a primary care dataset of 20,510 multi-ethnic individuals with T2DM from London, UK (2007–2018). Discrimination and calibration of the resulting prediction models developed using cox regression were assessed using the c-statistic and calibration slope, respectively. Models were internally validated using tenfold cross-validation and externally validated on 13,346 primary care individuals from Wales, UK. The simplest model was simplified into a risk score to enable implementation in community-based medicine. The derived full model included demographic, laboratory parameters, medication-use, cardiovascular disease history (CVD) and sight threatening retinopathy status (STDR). Two less resource-intense models were developed by excluding CVD and STDR in the second model and HbA1c and HDL in the third model. All three 5-year risk models had good internal discrimination and calibration (optimism adjusted C-statistics were each 0.85 and calibration slopes 0.999–1.002). In Wales, models achieved excellent discrimination(c-statistics ranged 0.82–0.83). Calibration slopes at 5-years suggested models over-predicted risks, however were successfully updated to accommodate reduced incidence of stage 3 CKD in Wales, which improved their alignment with the observed rates in Wales (E/O ratios near to 1). The risk score demonstrated similar model performance compared to direct evaluation of the cox model. These resource-driven risk prediction models may enable universal screening for Stage 3 CKD to enable targeted early optimisation of risk factors for CKD.Sarega GurudasManjula NugawelaA. Toby PrevostThirunavukkarasu SathishRohini MathurJ. M. RaffertyKevin BligheRamachandran RajalakshmiAnjana R. MohanJebarani SaravananAzeem MajeedViswanthan MohanDavid R. OwensJohn RobsonSobha Sivaprasadthe ORNATE India Study GroupNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Sarega Gurudas Manjula Nugawela A. Toby Prevost Thirunavukkarasu Sathish Rohini Mathur J. M. Rafferty Kevin Blighe Ramachandran Rajalakshmi Anjana R. Mohan Jebarani Saravanan Azeem Majeed Viswanthan Mohan David R. Owens John Robson Sobha Sivaprasad the ORNATE India Study Group Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes |
description |
Abstract Prediction models for population-based screening need, for global usage, to be resource-driven, involving predictors that are affordably resourced. Here, we report the development and validation of three resource-driven risk models to identify people with type 2 diabetes (T2DM) at risk of stage 3 CKD defined by a decline in estimated glomerular filtration rate (eGFR) to below 60 mL/min/1.73m2. The observational study cohort used for model development consisted of data from a primary care dataset of 20,510 multi-ethnic individuals with T2DM from London, UK (2007–2018). Discrimination and calibration of the resulting prediction models developed using cox regression were assessed using the c-statistic and calibration slope, respectively. Models were internally validated using tenfold cross-validation and externally validated on 13,346 primary care individuals from Wales, UK. The simplest model was simplified into a risk score to enable implementation in community-based medicine. The derived full model included demographic, laboratory parameters, medication-use, cardiovascular disease history (CVD) and sight threatening retinopathy status (STDR). Two less resource-intense models were developed by excluding CVD and STDR in the second model and HbA1c and HDL in the third model. All three 5-year risk models had good internal discrimination and calibration (optimism adjusted C-statistics were each 0.85 and calibration slopes 0.999–1.002). In Wales, models achieved excellent discrimination(c-statistics ranged 0.82–0.83). Calibration slopes at 5-years suggested models over-predicted risks, however were successfully updated to accommodate reduced incidence of stage 3 CKD in Wales, which improved their alignment with the observed rates in Wales (E/O ratios near to 1). The risk score demonstrated similar model performance compared to direct evaluation of the cox model. These resource-driven risk prediction models may enable universal screening for Stage 3 CKD to enable targeted early optimisation of risk factors for CKD. |
format |
article |
author |
Sarega Gurudas Manjula Nugawela A. Toby Prevost Thirunavukkarasu Sathish Rohini Mathur J. M. Rafferty Kevin Blighe Ramachandran Rajalakshmi Anjana R. Mohan Jebarani Saravanan Azeem Majeed Viswanthan Mohan David R. Owens John Robson Sobha Sivaprasad the ORNATE India Study Group |
author_facet |
Sarega Gurudas Manjula Nugawela A. Toby Prevost Thirunavukkarasu Sathish Rohini Mathur J. M. Rafferty Kevin Blighe Ramachandran Rajalakshmi Anjana R. Mohan Jebarani Saravanan Azeem Majeed Viswanthan Mohan David R. Owens John Robson Sobha Sivaprasad the ORNATE India Study Group |
author_sort |
Sarega Gurudas |
title |
Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes |
title_short |
Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes |
title_full |
Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes |
title_fullStr |
Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes |
title_full_unstemmed |
Development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes |
title_sort |
development and validation of resource-driven risk prediction models for incident chronic kidney disease in type 2 diabetes |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/ed6372bb348e41e0939b2808d1e378b6 |
work_keys_str_mv |
AT saregagurudas developmentandvalidationofresourcedrivenriskpredictionmodelsforincidentchronickidneydiseaseintype2diabetes AT manjulanugawela developmentandvalidationofresourcedrivenriskpredictionmodelsforincidentchronickidneydiseaseintype2diabetes AT atobyprevost developmentandvalidationofresourcedrivenriskpredictionmodelsforincidentchronickidneydiseaseintype2diabetes AT thirunavukkarasusathish developmentandvalidationofresourcedrivenriskpredictionmodelsforincidentchronickidneydiseaseintype2diabetes AT rohinimathur developmentandvalidationofresourcedrivenriskpredictionmodelsforincidentchronickidneydiseaseintype2diabetes AT jmrafferty developmentandvalidationofresourcedrivenriskpredictionmodelsforincidentchronickidneydiseaseintype2diabetes AT kevinblighe developmentandvalidationofresourcedrivenriskpredictionmodelsforincidentchronickidneydiseaseintype2diabetes AT ramachandranrajalakshmi developmentandvalidationofresourcedrivenriskpredictionmodelsforincidentchronickidneydiseaseintype2diabetes AT anjanarmohan developmentandvalidationofresourcedrivenriskpredictionmodelsforincidentchronickidneydiseaseintype2diabetes AT jebaranisaravanan developmentandvalidationofresourcedrivenriskpredictionmodelsforincidentchronickidneydiseaseintype2diabetes AT azeemmajeed developmentandvalidationofresourcedrivenriskpredictionmodelsforincidentchronickidneydiseaseintype2diabetes AT viswanthanmohan developmentandvalidationofresourcedrivenriskpredictionmodelsforincidentchronickidneydiseaseintype2diabetes AT davidrowens developmentandvalidationofresourcedrivenriskpredictionmodelsforincidentchronickidneydiseaseintype2diabetes AT johnrobson developmentandvalidationofresourcedrivenriskpredictionmodelsforincidentchronickidneydiseaseintype2diabetes AT sobhasivaprasad developmentandvalidationofresourcedrivenriskpredictionmodelsforincidentchronickidneydiseaseintype2diabetes AT theornateindiastudygroup developmentandvalidationofresourcedrivenriskpredictionmodelsforincidentchronickidneydiseaseintype2diabetes |
_version_ |
1718378189934297088 |